BBA

Baker Bros. Advisors Portfolio holdings

AUM $10.3B
This Quarter Return
-0.11%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$7.97B
AUM Growth
+$7.97B
Cap. Flow
+$3.4M
Cap. Flow %
0.04%
Top 10 Hldgs %
77.13%
Holding
96
New
12
Increased
15
Reduced
7
Closed
7
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ACHL
76
DELISTED
Achilles Therapeutics plc American Depositary Shares
ACHL
$1.51M 0.02%
1,208,775
-894,017
-43% -$1.12M
GBIO icon
77
Generation Bio
GBIO
$40.3M
$1.51M 0.02%
+37,122
New +$1.51M
MURA icon
78
Mural Oncology
MURA
$35.9M
$1.09M 0.01%
+222,503
New +$1.09M
PFE icon
79
Pfizer
PFE
$141B
$971K 0.01%
35,000
TARA icon
80
Protara Therapeutics
TARA
$125M
$801K 0.01%
199,671
PMVP icon
81
PMV Pharmaceuticals
PMVP
$82.1M
$547K 0.01%
322,024
ACRV icon
82
Acrivon Therapeutics
ACRV
$42.2M
$378K ﹤0.01%
+52,885
New +$378K
FHTX icon
83
Foghorn Therapeutics
FHTX
$298M
$302K ﹤0.01%
45,027
CABA icon
84
Cabaletta Bio
CABA
$144M
$227K ﹤0.01%
13,331
CATX icon
85
Perspective Therapeutics
CATX
$251M
$178K ﹤0.01%
14,979
-748,991
-98% -$8.91M
TYRA icon
86
Tyra Biosciences
TYRA
$657M
$174K ﹤0.01%
10,607
SRZNW icon
87
Surrozen, Inc. Warrant
SRZNW
$71.9K
$25.2K ﹤0.01%
833,333
DAWN icon
88
Day One Biopharmaceuticals
DAWN
$766M
-1,000,000
Closed -$14.6M
SPRY icon
89
ARS Pharmaceuticals
SPRY
$1.08B
-2,006,451
Closed -$11M
WHWK
90
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$85.3M
-251,727
Closed -$508K
BCEL
91
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
-2,177,499
Closed -$287K
GRCL
92
DELISTED
Gracell Biotechnologies Inc. American Depositary Shares
GRCL
-2,080,000
Closed -$20.9M
NVTA
93
DELISTED
Invitae Corporation
NVTA
-1,764,546
Closed -$1.11M
MRTX
94
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-4,121,440
Closed -$242M